{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T11:37:27Z","timestamp":1760441847701,"version":"3.37.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1530, C01"],"award-info":[{"award-number":["SFB1530, C01"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-024-01968-0","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T12:01:34Z","timestamp":1727092894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Checkpoint blockade therapy in Hodgkin lymphoma: improved response through combination with JAK inhibition"],"prefix":"10.1038","volume":"9","author":[{"given":"Marc A.","family":"Weniger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6691-7191","authenticated-orcid":false,"given":"Ralf","family":"K\u00fcppers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"1968_CR1","doi-asserted-by":"publisher","first-page":"eade8520","DOI":"10.1126\/science.ade8520","volume":"384","author":"J Zak","year":"2024","unstructured":"Zak, J. et al. JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science 384, eade8520 (2024).","journal-title":"Science"},{"key":"1968_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2018.09.008","volume":"194","author":"A Constantinidou","year":"2019","unstructured":"Constantinidou, A., Alifieris, C. & Trafalis, D. T. Targeting programmed cell death-1 (PD-1) and ligand (PD-L1): a new era in cancer active immunotherapy. Pharm. Ther. 194, 84\u2013106 (2019).","journal-title":"Pharm. Ther."},{"key":"1968_CR3","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","volume":"35","author":"MA Weniger","year":"2021","unstructured":"Weniger, M. A. & K\u00fcppers, R. Molecular biology of Hodgkin lymphoma. Leukemia 35, 968\u2013981 (2021).","journal-title":"Leukemia"},{"key":"1968_CR4","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1097\/HS9.0000000000000020","volume":"2","author":"RH Moy","year":"2018","unstructured":"Moy, R. H. & Younes, A. Immune checkpoint inhibition in Hodgkin lymphoma. Hemasphere 2, e20 (2018).","journal-title":"Hemasphere"},{"key":"1968_CR5","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","volume":"4","author":"MGM Romer","year":"2016","unstructured":"Romer, M. G. M. et al. Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status. Cancer Immunol. Res. 4, 910\u2013916 (2016).","journal-title":"Cancer Immunol. Res."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01968-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01968-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01968-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T05:49:20Z","timestamp":1727156960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01968-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1968"],"URL":"https:\/\/doi.org\/10.1038\/s41392-024-01968-0","relation":{},"ISSN":["2059-3635"],"issn-type":[{"type":"electronic","value":"2059-3635"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"250"}}